Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: KHS who wrote (19743)	3/14/1999 10:24:00 AM
From: Zebra 365	Read Replies (5) \| Respond to of 23519

Don't count too much that the rally was due to the Patent press release. Just because the rooster crows and the sun comes up, does not mean the rooster made the sun come up. The volume of that spike tells you that pros and institutions were buying. The female sexual patent was known to most of us 5 days earlier, I have to assume that major buyers were not surprised by the press release. We are a long way from a marketable product in that area. I think there was something else driving the buying. Whether it was hedged short covering or opening new positions, that Press release was not enough to drive it to what we saw. TA is very strong on the stock when viewed on a daily interval basis: iqc.com I'm sorry but this strength on MACD does not come from a press release about a product that has yet to be created. Just IMHO, I'm still waiting for the real story. Zebra

To: KHS who wrote (19743)	3/14/1999 4:06:00 PM
From: Edderd	Respond to of 23519

KHS Might be but you better catch their attention or it will be the great circular file in a lot of cases. Ed

To: KHS who wrote (19743)	3/14/1999 4:21:00 PM
From: BigKNY3	Read Replies (4) \| Respond to of 23519

KLS, here are 5 of the studies supported by VVUS that will be presented at the 1999 AUA Annual Meeting during May 1-6: -Gene therapy with K+ channels preserves erectile capacity in the face of diminished neuronal innervation following 12-16 weeks of experimental diabetes in rats (#806 Presented by Dr. George Christ) -The expression of HSLO transcript is largely locally restricted following intracavernous injection (# 807 Presented by Dr. George Christ) -Induction of penile erection by intracavernosal and transurethral administration of zaprinast (a PDE-5 inhibitor) and PGE1 (#848) -Efficacy of MUSE in patients with erectile dysfunction who failed with Viagra Therapy: Results from a multicenter post-marketing study (#813) -Does renewed sexual activity increase cardiac morbidity? Meta-analysis of the experience with MUSE (#823) BigKNY3